From: Role of senescence and mitotic catastrophe in cancer therapy
Characteristics | Mitotic catastrophe | Senescence |
---|---|---|
Definition | Synonymous with 'Terminal proliferation arrest' may proceed with apoptosis or necrosis depending on molecular profile of the cell | Synonymous with 'Terminal growth arrest' Cell death in context of cancer |
Biomarker | Multinucleated giant cells, no specific in vitro and in vivo assay available | SA-β galactosidase expression, detected by X-gal staining |
Morphology | Aneuploidy, disrupted DNA index, micronuclei formation, nuclear envelope lacking, nuclear fragmentation and uncondensed chromatin | Flattened enlarged cells, granular cytoplasm, exhibit SAHF formation |
Genotype implicated in carcinogenesis | Accelerated by G1, G2 and prophase checkpoint proteins (ATM, ATR, p53, Chk2, Cdc25A, Cdc25B, Plk1 & 3) | Accelerated by telomere attrition, ras mutations, inhibited by ALT or p53 |
Inducing agents | Hyperthermia, IR, anti-cancer drugs interfering with DNA or microtubule assembly | Spontaneous as a result of cumulative divisions or challenged by oncogenic stimulus |